Life Extension Bio-Fisetin
8 mg fisetin per capsule
Low-dose fisetin with fenugreek galactomannans.
Best for: reviewing a low-dose fisetin label in Key Facts
View on Amazon · Affiliate link
Evidence correction: Human senolytic research is early and does not establish an over-the-counter or self-directed anti-aging regimen.
Multiple senolytic clinical trials are actively recruiting in the US and internationally as of 2026. Trial participation provides free access to physician-supervised senolytic treatment, comprehensive safety monitoring, and contribution to science — at no cost to participants. The primary barrier is meeting eligibility criteria, which typically include age (≥65), specific health characteristics, and geographic proximity to a trial site.
As an Amazon Associate, Stacking Years earns from qualifying purchases.
8 mg fisetin per capsule
Low-dose fisetin with fenugreek galactomannans.
Best for: reviewing a low-dose fisetin label in Key Facts
View on Amazon · Affiliate link
Amazon search listings only; no specific product or label dose is verified by us.
Best for: comparing current spermidine listings in Key Facts; no pick is verified
View on Amazon · Affiliate link
Can I continue taking supplement senolytics while in a clinical trial?
Always disclose all supplements to trial investigators. Some trials exclude participants taking senolytics or require a washout period. Others allow continuation of supplements. Never conceal supplement use from trial staff.
What if I'm randomized to placebo?
Placebo assignment is frustrating but provides essential scientific data. After trial completion, many trials offer open-label extension periods where all participants receive active treatment. Ask the trial team about post-trial access.
Senolytics are compounds intended to influence senescent cells. Most evidence that they can clear these cells or improve healthspan comes from cell and animal experiments. Human research is still testing feasibility, safety, biomarkers, and disease-specific outcomes; it has not established a routine anti-aging treatment.
One randomized phase I pilot in idiopathic pulmonary fibrosis enrolled 12 clinically stable participants, six per group, to assess intermittent dasatinib plus quercetin (D+Q) feasibility and tolerability. The sample was too small to determine clinical efficacy, and the investigators cautioned against interpreting exploratory outcomes as proof of benefit. Earlier open-label work in IPF also enrolled only 14 people and had no control group. Newer early-stage studies in older adults have similarly small samples. Small studies can identify practical safety signals, but cannot show that an intervention prevents disease or extends life.
250 mg quercetin phytosome per capsule
Quercetin phytosome capsules.
Best for: comparing a quercetin phytosome option in Human trials are early, small, and disease-specific
View on Amazon · Affiliate link
Check whether a trial is randomized, controlled, and adequately sized; whether the outcome is a laboratory marker or a patient-important measure; how long participants were followed; and whether harms were systematically recorded. A change in a senescence-associated marker does not prove that senescent cells were selectively removed. Results in people with a specific illness cannot be generalized to healthy adults.
Dasatinib is a prescription cancer medicine with potentially serious adverse effects and interactions. Quercetin supplements are not equivalent to the drug combination used in trials. Fisetin and other dietary compounds also lack an established over-the-counter senolytic protocol. Do not self-prescribe intermittent drug regimens based on a research paper.
FAQ
Are senolytics proven to extend human life? No.
Can I copy a trial dose? No. Trial protocols are designed for monitored research participants and require medical oversight.
See the D+Q trial guide and fisetin safety profile.
Research: Randomized phase I IPF pilot; PubMed record and abstract; 2025 SToMP-AD/STAMINA review.